Intellectual Property
Patents
Eurand’s owned and in-licensed patent portfolio contains approximately 100 patent families that consist of over 398 granted patents and more than 299 pending applications.
This portfolio is composed of patents with claims directed to our formulation technologies and related materials, processes, equipment and methods of manufacture. We also have many product-related patents, which contain more specific claims directed to particular drugs or classes of drugs in combination with our formulation technology.
Eurand endeavors to offer the most effective patent protection possible to our partners based on our broad and diversified portfolio of pharmaceutical technologies.
Trademarks
Eurand has registered, and/or pending applications for the registration of, certain trademarks in various countries, which allow the company to create brand recognition of our technologies and enhance loyalty within our customer base.